Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Australia not worried about vaccine trial pause, cases rise in hot spot

CoronavirusSep 08, 2020 09:15PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Disinfectant products are seen on a car whilst motorists fill out paperwork for police as they cross back into South Australia from Victoria during the coronavirus disease (COVID-19) outbreak, in Bordertown

By Renju Jose

SYDNEY (Reuters) - Australia is not worried about AstraZeneca (NYSE:AZN) Plc's decision to put on hold its COVID-19 vaccine trial, its deputy chief medical officer said on Wednesday, as daily cases nudged higher in the country's coronavirus hot spot.

AstraZeneca on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.

The nature of the case and when it happened were not detailed, although the participant is expected to recover, according to Stat News, which first reported the news.

"With the information that I have got at the moment, I am not worried about it," Australia's Deputy Chief Medical Officer Nick Coatsworth told Sky News, adding the hold on trials does not mean the vaccine "is off the table".

"In some respects, this is a very positive thing because it shows that despite the accelerated vaccine development, safety is the priority of the clinical trialists and investigators."

Coatsworth said Australia like many other governments has invested in several coronavirus vaccine candidates, "knowing not all of them will get through".

AstraZeneca's decision to place the trial on hold comes after a pledge from nine leading U.S. and European vaccine developers on Tuesday to uphold scientific safety and efficacy standards for their vaccines despite the urgency to contain the pandemic.

Australia on Monday said it would get the first doses of AstraZeneca's vaccine in January 2021 if trials proved successful after reaching a preliminary deal in August.

It had also signed an agreement on a COVID-19 vaccine being developed by the University of Queensland. Both these vaccines will be manufactured locally by CSL (OTC:CSLLY) Ltd.

Australia's coronavirus hot spot of Victoria on Wednesday, meanwhile, reported its biggest rise in daily cases in three days as the state boosted its contact tracing programme to ease the spread of the virus.

Victoria, which is at the centre of Australia's second wave of coronavirus outbreak, now accounts for about 75% of Australia's 26,450 COVID-19 cases and 90% of its 781 deaths.

The state reported 76 new cases and 11 deaths from the virus in the last 24 hours.

Australia not worried about vaccine trial pause, cases rise in hot spot
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email